These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 63527)

  • 1. Histocompatibility antigens in patients with leprosy.
    Rea TH; Levan NE; Terasaki PI
    J Infect Dis; 1976 Dec; 134(6):615-8. PubMed ID: 63527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Humoral and cellular immune reactivity to recombinant M. leprae antigens in HLA-typed leprosy patients and healthy controls.
    Klatser PR; Janson AM; Thole JE; Buhrer S; Bos C; Soebono H; de Vries RR
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):178-89. PubMed ID: 9251589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of major histocompatibility complex class I and class II antigens in human Schwann cell cultures and effects of infection with Mycobacterium leprae.
    Samuel NM; Mirsky R; Grange JM; Jessen KR
    Clin Exp Immunol; 1987 Jun; 68(3):500-9. PubMed ID: 3115648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-linked genetic control of host response to Mycobacterium leprae.
    de Vries RR; Fat RF; Nijenhuis LE; van Rood JJ
    Lancet; 1976 Dec; 2(7999):1328-30. PubMed ID: 63804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study of cell-mediated immunity and histocompatibility antigens in leprosy patients in Iran.
    Massoud A; Nikbin B; Nazari GR; Syadat NA; Ala F
    Int J Lepr Other Mycobact Dis; 1978; 46(2):149-53. PubMed ID: 308050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histocompatibility antigens in patients with leprosy from Azarbaijan, Iran.
    Mohagheghpour N; Tabatabai H; Mohammad K; Ramanujam K; Modabber FZ
    Int J Lepr Other Mycobact Dis; 1979 Dec; 47(4):597-600. PubMed ID: 122630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA antigens and neural reversal reactions in Ethiopian borderline tuberculoid leprosy patients.
    Ottenhoff TH; Converse PJ; Bjune G; de Vries RR
    Int J Lepr Other Mycobact Dis; 1987 Jun; 55(2):261-6. PubMed ID: 3474306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA antigen and susceptibility to leprosy.
    Nakajima S; Kobayashi S; Nohara M; Sato S
    Int J Lepr Other Mycobact Dis; 1977; 45(3):273-7. PubMed ID: 562857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular localization and polymorphism of HLA class II restriction determinants defined by Mycobacterium leprae-reactive helper T cell clones from leprosy patients.
    Ottenhoff TH; Neuteboom S; Elferink DG; de Vries RR
    J Exp Med; 1986 Dec; 164(6):1923-39. PubMed ID: 2431092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histocompatibility antigens (HL-A) in leprosy.
    Dasgupta A; Mehra NK; Ghei SK; Vaidya MC
    Tissue Antigens; 1975 Apr; 5(2):85-7. PubMed ID: 1129752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histocompatibility antigens in leprosy.
    Smith GS; Walford RL; Shepard CC; Payne R; Prochazka GJ
    Vox Sang; 1975; 28(1):42-9. PubMed ID: 1114785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of some of the HL-A system lymphocyte antigens in Mexicans. II. Studies in atopics and in lepers.
    Escorbar-Gutiérrez A; Gorodezky C; Salazar-Mallén M
    Vox Sang; 1973; 25(2):151-5. PubMed ID: 4737546
    [No Abstract]   [Full Text] [Related]  

  • 13. T cell responses to fractionated Mycobacterium leprae antigens in leprosy. The lepromatous nonresponder defect can be overcome in vitro by stimulation with fractionated M. leprae components.
    Ottenhoff TH; Converse PJ; Gebre N; Wondimu A; Ehrenberg JP; Kiessling R
    Eur J Immunol; 1989 Apr; 19(4):707-13. PubMed ID: 2659369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immunobiology of leprosy.
    Kaplan G; Cohn ZA
    Int Rev Exp Pathol; 1986; 28():45-78. PubMed ID: 3516911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloned suppressor T cells from a lepromatous leprosy patient suppress Mycobacterium leprae reactive helper T cells.
    Ottenhoff TH; Elferink DG; Klatser PR; de Vries RR
    Nature; 1986 Jul 31-Aug 6; 322(6078):462-4. PubMed ID: 2426597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA and leprosy in the pre and postgenomic eras.
    Geluk A; Ottenhoff TH
    Hum Immunol; 2006 Jun; 67(6):439-45. PubMed ID: 16728267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetically restricted suppressor T-cell clones derived from lepromatous leprosy lesions.
    Modlin RL; Kato H; Mehra V; Nelson EE; Fan XD; Rea TH; Pattengale PK; Bloom BR
    Nature; 1986 Jul 31-Aug 6; 322(6078):459-61. PubMed ID: 2942780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The HLA antigens and leprosy in Thailand.
    Chiewsilp P; Athkambhira S; Chirachariyavej T; Bhamarapravati N; Entwistle C
    Tissue Antigens; 1979 Mar; 13(3):186-8. PubMed ID: 87028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excavating the surface-associated and secretory proteome of Mycobacterium leprae for identifying vaccines and diagnostic markers relevant immunodominant epitopes.
    Rana A; Thakur S; Bhardwaj N; Kumar D; Akhter Y
    Pathog Dis; 2016 Dec; 74(9):. PubMed ID: 27856491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Distribution of various HL-A antigens in Mexico. Studies in the general (Mestizo and Indian) and atopic and leper populations].
    Gutiérrez AE; Gorodezky C
    Rev Invest Salud Publica; 1974; 34(4):161-8. PubMed ID: 4456514
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.